Langcoquinone A (248) |
Spongia sp. |
Antimicrobial effects: Staphylococcus aureus = MIC 12.5 μM; Bacillus subtilis = MIC 12.5 μM |
[82] |
Langcoquinone B (249) |
Spongia sp. |
Antimicrobial effects: Staphylococcus aureus = MIC 12.5 μM; Bacillus subtilis = MIC 12.5 μM |
[82] |
Langconol A (250) |
|
Antimicrobial effects: B. subtilis MIC 12.5 μM |
[83] |
Langconol C (252) |
|
Antimicrobial effects: B. subtilis = MIC 25.0 μM |
[83] |
Langcoquinone C (253) |
|
Antimicrobial effects: Staphylococcus aureus = MIC 12.50 μM; Bacillus subtilis = MIC 6.25 μM |
[83] |
Aminoquinone (257) |
Dysidea sp. |
Antimicrobial effects: B. subtilis = MIC 50.0 μg/mL; S. aureus = MIC 50.0 μg/mL; E. coli = MIC 50.0 μg/mL |
[84] |
Nakijinol G (267) |
Hyrtios sp. |
Enzyme Inhibition: PTP1B = IC50 4.8 μM |
[87] |
Dysivillosin A (270) |
Dysidea villosa
|
Enzyme Inhibition: β-hexosaminidase = IC50 8.2 μM |
[88] |
Dysivillosin B (271) |
|
Enzyme Inhibition: β-hexosaminidase = IC50 10.2 μM |
[88] |
Dysivillosin C (272) |
|
Enzyme Inhibition: β-hexosaminidase = IC50 19.9 μM |
[88] |
Dysivillosin D (273) |
|
Enzyme Inhibition: β-hexosaminidase = IC50 16.2 μM |
[88] |
Chartarolide A (274) |
Niphates recondite
|
Cytotoxic effects: HCT-116 = IC50 1.9 μM; HepG2 = IC50 1.8 μM; BGC-823 = IC50 1.3 μM; NCI-H1650 = IC50 5.5 μM; A2780 = IC50 1.5 μM; MCF7 = IC50 1.4 μM |
[90] |
Chartarolide B (275) |
Niphates recondite
|
Cytotoxic effects: HCT-116 = IC50 2.3 μM; HepG2 = IC50 2.8 μM; BGC-823 = IC50 1.6 μM; NCI-H1650 = IC50 4.8 μM; A2780 = IC50 3.2 μM; MCF7 = IC50 3.8 μM |
[90] |
Chartarolide C (276) |
Niphates recondite
|
Cytotoxic effects: HCT-116 = IC50 7.8 μM; HepG2 = IC50 8.9 μM; BGC-823 = IC50 5.4 μM; NCI-H1650 = IC50 11.3 μM; A2780 = IC50 12.5 μM; MCF7 = IC50 8.7 μM |
[90] |
Terretonin N (304) |
Nocardiopsis sp. |
Antimicrobial effects: S. warneri = IZ 14 mm E. coli = IZ 8 mm |
[98] |
Rubiginosin A (306) |
Rhododendron rubiginosum
|
Cytotoxic effects: A549 = IC50 16.15 μM; HCT116 = IC50 15.56 μM; SK-HEP-1 = IC50 13.80 μM; HL-60 = IC50 12.84 μM |
[101] |
Rubiginosin B (307) |
Rhododendron rubiginosum
|
Cytotoxic effects: HCT116 = IC50 65.72 μM; SK-HEP-1 = IC50 84.66 μM |
[101] |
Rubiginosin C (308) |
Rhododendron rubiginosum
|
Cytotoxic effects: A549 = IC50 40.45 μM; HCT116 = IC50 17.43 μM; SK-HEP-1 = IC50 26.26 μM; HL-60 = IC50 16.44 μM |
[101] |
Rubiginosin D (309) |
Rhododendron rubiginosum
|
Cytotoxic effects: A549 = IC50 49.18 μM; HCT116 = IC50 32.17 μM; SK-HEP-1 = IC50 13.66 μM; HL-60 = IC50 40.07 μM |
[101] |
Rubiginosin E (310) |
Rhododendron rubiginosum
|
Cytotoxic effects: A549 = IC50 38.90 μM; HCT116 = IC50 38.90 μM; SK-HEP-1 = IC50 38.90 μM; HL-60 = IC50 38.90 μM |
[101] |
Rubiginosin F (311) |
Rhododendron rubiginosum
|
Cytotoxic effects: A549 = IC50 38.90 μM; HCT116 = IC50 38.90 μM; SK-HEP-1 = IC50 38.90 μM; HL-60 = IC50 38.90 μM |
[101] |
Rubiginosins G (312) |
Rhododendron rubiginosum
|
Cytotoxic effects: A549 = IC50 38.90 μM; HCT116 = IC50 38.90 μM; SK-HEP-1 = IC50 38.90 μM; HL-60 = IC50 38.90 μM |
[101] |
Anthopogochromene A (313) |
Rhododendron rubiginosum
|
Cytotoxic effects: A549 = IC50 38.90 μM; HCT116 = IC50 38.90 μM; SK-HEP-1 = IC50 38.90 μM; HL-60 = IC50 38.90 μM |
[101] |
Anthopogochromene B (314) |
Rhododendron rubiginosum
|
Cytotoxic effects: A549 = IC50 38.90 μM; HCT116 = IC50 38.90 μM; SK-HEP-1 = IC50 38.90 μM; HL-60 = IC50 38.90 μM |
[101] |
Isopolycerasoidol (315) |
Sargassum siliquastrum
|
Antioxidant effects: DPPH = EC50 8.23 μM; ABTS = EC50 2.33 μM |
[103] |
Sargachromanol D (316) |
Sargassum siliquastrum
|
Antioxidant effects: DPPH = EC50 26.35 μM; ABTS = EC50 4.84 μM |
[103] |
Sargachromanol E (317) |
Sargassum siliquastrum
|
Antioxidant effects: DPPH = EC50 23.84 μM; ABTS = EC50 4.57 μM |
[103] |
Sargachromanol G (318) |
Sargassum siliquastrum
|
Antioxidant effects: DPPH = EC50 33.43 μM; ABTS = EC50 4.05 μM |
[103] |
Sargachromanol I (319) |
Sargassum siliquastrum
|
Antioxidant effects: DPPH = EC50 32.83 μM; ABTS = EC50 6.86 μM |
[103] |